A Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Trial Investigating the Efficacy and Safety of Two Different Dose Levels of Desmopressin for the Treatment of Nocturia in Adult Men
Phase of Trial: Phase II
Latest Information Update: 22 Aug 2013
Price : $35 *
At a glance
- Drugs Desmopressin (Primary)
- Indications Nocturia
- Focus Therapeutic Use
- Sponsors Ferring Pharmaceuticals
- 01 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Oct 2012 New trial record